A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy-Reference-Cited by-同舟云学术

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Published:2006-09 Issue:9 Volume:17 Page:1441-1449
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Aapro M.S.,Grunberg S.M.,Manikhas G.M.,Olivares G.,Suarez T.,Tjulandin S.A.,Bertoli L.F.,Yunus F.,Morrica B.,Lordick F.,Macciocchi A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/9/1441/569656/mdl137.pdf

Reference49 articles.

1. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice;Hesketh;Oncologist,1999

2. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology–Antiemesis—v.1. 2005. Available at: http://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf. Date last accessed: March 1, 2005.

3. 2004 Perugia Antiemetic Consensus Guidelines;Multinational Association of Supportive Care in Cancer (MASCC);Support Care Cancer,2005

4. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: a comparison of their pharmacology and clinical efficacy;Gregory;Drugs,1998

5. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy;Kris;Support Care Cancer,2005

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B);Annals of Oncology;2024-09

2. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

3. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25

4. A prospective randomized controlled clinical trial investigating the efficacy of low-dose olanzapine in preventing nausea and vomiting associated with oxaliplatin-based and irinotecan-based chemotherapy;Journal of Cancer Research and Clinical Oncology;2024-05-28

5. Bibliometric and visual analysis of chemotherapy-induced nausea and vomiting (2004-2023);Frontiers in Oncology;2024-04-24